Trial Information
Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
Inclusion Criteria:
- 18 years of age or older
- Patient meets the clinical and/or pathologic criteria for the cutaneous or
hematologic disorder being examined.
- Patient is willing to provide skin biopsies and five 10 mL tubes of peripheral blood.
Exclusion Criteria:
- Less than 18 years of age
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Outcome Measure:
Number of mutations
Outcome Description:
Identify mutations, changes in DNA copy number, structural rearrangements, or altered coding and non-coding RNA expression
Outcome Time Frame:
2 years
Safety Issue:
No
Principal Investigator
Paul Khavari, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Stanford University
Authority:
United States: Institutional Review Board
Study ID:
LYMNHL0091
NCT ID:
NCT01556828
Start Date:
June 2011
Completion Date:
April 2015
Related Keywords:
- Cutaneous Lymphoma
- Other Skin Disorders
- Mycosis Fungoides
- Cutaneous T-cell Lymphoma
- Hematologic Diseases
- Lymphoma
- Mycoses
- Mycosis Fungoides
- Skin Diseases
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
Name | Location |
Stanford University Cancer Institute |
Stanford, California 94305 |